Whitepaper: Phys.- Chem. Characterisation of NCEs in Pre-Formulation: Use of In silico Tools

Add bookmark

As solubility (or rather poor solubility) is one of the hot topics in drug development, there is a strong interest in gaining solubility data early on, at a stage of a project where there is still a multitude of candidates investigated in parallel. So it is not surprising that there have been widely used approaches to calculate solubility in drug research, as well as doing the same for dissolution rate and more importantly bioavailability / in-vivo absorption during drug development.

This industry whitepaper highlights some rather practical considerations, used by Merck when looking into In-silico tools.
 

Upcoming Events

DigIT Pharma 2026 | AI Commercial, Medical & Patient Care

September 9 - 10, 2026

Steigenberger Airport Hotel Berlin, Deutschland

DigIT Pharma 2026 | AI Commercial, Medical & Patient Care

Pharmaceutical Launch Excellence Summit US

September 30 - October 1 2026

Hyatt Regency Boston Harbor, Boston, US

Pharmaceutical Launch Excellence Summit US

SmartLab Exchange Europe

22 - 23 February 2027

Leonardo Royal Hotel Amsterdam, Netherlands

SmartLab Exchange Europe

Latest Webinars

Pharma IQ's Power List 2022: In conversation with pharma's top leaders

2022-10-18

02:00 PM - 03:00 PM BST

Join us to hear from the most influential people in pharma today, as voted for by you

A post-pandemic 3D view of the patient and supply journey

2022-06-01

04:30 PM - 05:30 PM CET

In this panel discussion with experts from 4G Clinical, THREAD Research and World Courier, learn how...

Discover how targeted radiotherapy induced toxicity can be identified with imaging

2022-04-28

01:00 PM - 02:00 PM EST

This Pharma IQ webinar with AIQ explores how AI-assisted analysis of radiological scans enhances the...

Recommended